Table 2.
Cochlear implant programming parameters and usage
| Participant | Current Pre-processing Strategy | Channel Rate | Maxima | Years of CI use since initial stimulation | Mean EDR in clinical units (1st ear stimulated) | Mean EDR in clinical units (2nd ear stimulated) |
|---|---|---|---|---|---|---|
| 1 | No pre-processing | 900 | 12 | 10.50 | 31.35 | |
| 2 | ADRO® | 900 | 8 | 12.50 | 32.36 | 25.00 |
| 3 | ASC+ADRO® | 900 | 10 | 6.00 | 44.95 | |
| 4 | ADRO® | 900 | 12 | 10.92 | 53.14 | 35.91 |
| 5 | ADRO® | 900 | 8 | 10.50 | 43.75 | 43.59 |
| 6 | ADRO® | 1200 | 12 | 6.50 | 27.14 | 25.00 |
| 7 | No pre-processing | 900 | 9 | 9.50 | 36.20 | |
| 8 | ADRO® | 900 | 12 | 9.42 | 50.18 | |
| 9 | ADRO® | 1200 | 12 | 6.75 | 47.77 | |
| 10 | ASC+ADRO® | 1200 | 10 | 3.00 | 49.77 | 40.77 |
| 11 | ASC+ADRO® | 1200 | 12 | 6.83 | 61.29 | 55.00 |
Note: ADRO® = Automatic Dynamic Range Optimization; ASC+ADRO® = Autosensitivity control and Automatic Dynamic Range Optimization; CI = Cochlear Implant; EDR = Electrical Dynamic Range